Sangamo Therapeutics (SGMOQ) EBITDA Margin Growth (3y) (2013 - 2025)
Powered by 
Analysis
Sangamo Therapeutics (SGMOQ) EBITDA Margin Growth (3y) (2013 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.28 Bn | 9.43 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.20 Bn | 5.20 Bn | - | -101,581.00 |
| 3 | Iovance Biotherapeutics | 3.76 Bn | 3.46 Bn | 55.72 Mn | 4.62 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | -20,903.00 |
| 5 | uniQure | 3.07 Bn | 3.07 Bn | 5.49 Mn | 179,305.00 |
| 6 | Beam Therapeutics | 2.67 Bn | 2.67 Bn | - | -2.53 Mn |
| 7 | Precigen | 2.43 Bn | 2.43 Bn | 52.17 Mn | 123,643.00 |
| 8 | Sarepta Therapeutics | 2.34 Bn | 1.54 Bn | 251.87 Mn | 5,442.00 |
| 9 | Vericel | 2.00 Bn | 1.83 Bn | 56.40 Mn | 1,354.00 |
| 10 | Sangamo Therapeutics | 43.15 Mn | 22.20 Mn | - | -6,508.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -6,508.00 |
| Sep 30, 2025 | -591,182.00 |
| Jun 30, 2025 | 5,814.00 |
| Mar 31, 2025 | -29,995.00 |
| Dec 31, 2024 | -25,728.00 |
| Sep 30, 2024 | 19,109.00 |
| Jun 30, 2024 | -1.02 Mn |
| Mar 31, 2024 | -1.05 Mn |
| Dec 31, 2023 | -287,079.00 |
| Sep 30, 2023 | -112,583.00 |
| Jun 30, 2023 | -163,210.00 |
| Mar 31, 2023 | 35,190.00 |
| Sep 30, 2022 | 1,670.00 |
| Jun 30, 2022 | 14,645.00 |
| Mar 31, 2022 | 38,356.00 |
| Dec 31, 2021 | -6,517.00 |
| Sep 30, 2021 | -10,065.00 |
| Jun 30, 2021 | -8,535.00 |
| Mar 31, 2021 | -1,003.00 |
| Dec 31, 2020 | -6,307.00 |